UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

What Defines the Value of Minimally Invasive Surgery for Cancer Patients?

Annals of surgical oncology, 2024-04, Vol.31 (4), p.2204-2207

2024

Volltextzugriff (PDF)

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer

Annals of surgical oncology, 2015-07, Vol.22 (7), p.2416-2423

2015

Volltextzugriff (PDF)

Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C

Annals of surgical oncology, 2009-08, Vol.16 (8), p.2181-2187

2009

Volltextzugriff (PDF)

Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1919-1932

2024

Volltextzugriff (PDF)

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

Journal of gastrointestinal surgery, 2017, Vol.21 (1), p.164-174

2017

Volltextzugriff (PDF)

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment—A TAPS Consortium Study

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1954-1955

2024

Volltextzugriff (PDF)

Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center

Annals of surgical oncology, 2024-05, Vol.31 (5), p.3017-3023

2024

Volltextzugriff (PDF)

Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma

Annals of surgical oncology, 2023-10, Vol.30 (11), p.6662-6670

2023

Volltextzugriff (PDF)

Resection of At-Risk Mesenteric Lymph Nodes Is Associated with Improved Survival in Patients with Small Bowel Neuroendocrine Tumors

World journal of surgery, 2013-07, Vol.37 (7), p.1695-1700

2013

Volltextzugriff (PDF)

Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer

Journal of gastrointestinal surgery, 2023-02, Vol.27 (2), p.319-327

2023

Volltextzugriff (PDF)

Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

Journal of gastrointestinal surgery, 2014-02, Vol.18 (2), p.269-278

2014

Volltextzugriff (PDF)

Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy

Journal of gastrointestinal surgery, 2023-10, Vol.27 (10), p.2135-2144

2023

Volltextzugriff (PDF)

The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy

Annals of surgical oncology, 2015-12, Vol.22 (Suppl 3), p.1221-1228

2015

Volltextzugriff (PDF)

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

Annals of surgical oncology, 2010-07, Vol.17 (7), p.1794-1801

2010

Volltextzugriff (PDF)

Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection

Journal of gastrointestinal surgery, 2012-09, Vol.16 (9), p.1696-1704

2012

Volltextzugriff (PDF)

Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

Annals of surgical oncology, 2012-06, Vol.19 (6), p.2045-2053

2012

Volltextzugriff (PDF)

Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer

Journal of gastrointestinal surgery, 2012, Vol.16 (1), p.68-79

2012

Volltextzugriff (PDF)

After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant Readmissions

Journal of gastrointestinal surgery, 2016-01, Vol.20 (1), p.77-84

2016

Volltextzugriff (PDF)

Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater

Annals of surgical oncology, 2017-07, Vol.24 (7), p.2031-2039

2017

Volltextzugriff (PDF)

First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

Annals of surgical oncology, 2019-02, Vol.26 (2), p.619-627

2019

Volltextzugriff (PDF)

A High Positive Lymph Node Ratio is Associated with Distant Recurrence after Surgical Resection of Ampullary Carcinoma

Journal of gastrointestinal surgery, 2012-11, Vol.16 (11), p.2056-2063

2012

Volltextzugriff (PDF)

Adherence with operative standards in the treatment of gastric cancer in the United States

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-05, Vol.23 (3), p.550-560

2020

Volltextzugriff (PDF)

Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy

Journal of gastrointestinal surgery, 2022-05, Vol.26 (5), p.1054-1062

2022

Volltextzugriff (PDF)

Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma

Annals of surgical oncology, 2021-03, Vol.28 (3), p.1563-1569

2021

Volltextzugriff (PDF)

Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection

Journal of gastrointestinal surgery, 2020-02, Vol.24 (2), p.368-379

2020

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaMedicine

ThemaRetrospective Studies

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(30)
MEDLINE
(30)
SpringerNature Journals
(30)
Lippincott E Journal Collection
(16)
Ingenta.com
(15)
Wiley-Blackwell Full Collection
(2)
EZB Electronic Journals Library
(1)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What Defines the Value of Minimally Invasive Surgery for Cancer Patients?

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer

Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C

Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment—A TAPS Consortium Study

Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center

Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma

Resection of At-Risk Mesenteric Lymph Nodes Is Associated with Improved Survival in Patients with Small Bowel Neuroendocrine Tumors

Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer

Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy

The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection

Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer

After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant Readmissions

Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater

First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

A High Positive Lymph Node Ratio is Associated with Distant Recurrence after Surgical Resection of Ampullary Carcinoma

Adherence with operative standards in the treatment of gastric cancer in the United States

Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy

Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma

Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection

Aktive Filter

Suchergebnisse filtern